Congenital glioblastoma: A clinicopathologic and genetic analysis

Brain Pathology

Volumn 17, Issue 3, 2007, Pages 276-281

  Brat, Daniel J ^a,h   Shehata, Bahig M ^a   Castellano Sanchez, Amilcar A ^a   Hawkins, Cynthia ^b   Yost, Robert B ^c   Greco, Claudia ^d   Mazewski, Claire ^e   Janss, Anna ^e   Ohgaki, Hiroko ^f   Perry, Arie ^g  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Children's Healthcare of Atlanta ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Children's Healthcare of Atlanta   (United States)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P16; PROTEIN P53; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 10Q; CHROMOSOME 9P; CHROMOSOME DELETION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC ANALYSIS; GENETICS; GLIOBLASTOMA; HEMISPHERE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MALE; MITOSIS; NEUROIMAGING; NEUROSURGERY; NEWBORN; PATHOLOGY; PROTEIN EXPRESSION; TISSUE SECTION;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34347242483     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2007.00071.x     Document Type: Article

References (36)

1. Alonso M, Hamelin R, Kim M, Porwancher K, Sung T, Parhar P, Miller DC, Newcomb EW (2001) Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors. Cancer Res 61:2124 2128.
2. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461 3467.
3. Brat DJ, Castellano-Sanchez AA, Kaur B, Van Meir EG (2002) Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Adv Anat Pathol 9:24 36.
4. Bredel M, Pollack IF, Hamilton RL, James CD (1999) Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood. Clin Cancer Res 5:1786 1792.
5. Bvetow PC, Smirniotopoulos JG, Done S (1990) Congenital brain tumors: a review of 45 cases. AJR Am J Roentgenol 155:587 593.
6. Carstensen H, Juhler M, Bogeskov L, Laursen H (2006) A report of nine newborns with congenital brain tumours. Childs Nerv Syst 22:1427 1431.
7. Cheng Y, Ng HK, Zhang SF, Ding M, Pang JC, Zheng J, Poon WS (1999) Genetic alterations in pediatric high-grade astrocytomas. Hum Pathol 30:1284 1290.
8. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGurie P, Cherlow JM, Tefft M (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 13:112 123.
9. Fuller CE, Perry A (2002) Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology. Brain Pathol 12:67 86.
10. Fuller CE, Perry A (2005) Molecular diagnostics in central nervous system tumors. Adv Anat Pathol 12:180 194.
11. Geyer JR, Finlay JL, Boyett JM, Wisoff J, Yates A, Mao L, Packer RJ (1995) Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group. Cancer 75:1045 1050.
12. Gilbert-Barness E, Potter EL (1997) Potter's Pathology of the Fetus and Infant. Mosby:St. Louis.
13. Gilbertson RJ, Hill DA, Hernan R, Kocak M, Geyer R, Olson J, Gajjar A, Rush L, Hamilton RL, Finkelstein SD, Pollack IF (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res 9:3620 3624.
14. Haddad SF, Menezes AH, Bell WE, Godersky JC, Afifi AK, Bale JF (1991) Brain tumors occurring before 1 year of age: a retrospective reviews of 22 cases in an 11-year period (1977-1987). Neurosurgery 29:8 13.
15. Hunter SB, Brat DJ, Olson JJ, Von Deimling A, Zhou W, Van Meir EG (2003) Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review). Int J Oncol 23:857 869.
16. Isaacs H (1997) Tumors of the Fetus and Newborn. Saunders W.B.:Philadelphia, PA.
17. Kleihues P, Cavenee WK (2000) Pathology and Genetics of Tumours of the Nervous System. IARC Press:Lyon.
18. Kusafuka T, Miao J, Yoneda A, Kuroda S, Fukuzawa M (2004) Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor. Genes Chromosomes Cancer 40:133 139.
19. Leins AM, Kainer F, Weis S (2001) Sonography and neuropathology of a congenital brain tumor: report of a rare incident. Ultrasound Obstet Gynecol 17:245 247.
20. Mazewski CM, Hudgins RJ, Reisner A, Geyer JR (1999) Neonatal brain tumors: a review. Semin Perinatol 23:286 298.
21. Pollack IF, Finkelstein SD, Woods J, Burnham J, Hamilton RL, Yates AJ, Boyett JM, Finlay JL, Sposto R (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346:420 427.
22. Pollack IF, Hamilton RL, Finkelstein SD, Campbell JW, Martinez AJ, Sherwin RN, Bozik ME, Gollin SM (1997) The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res 57:304 309.
23. Raffel C, Frederick L, O'Fallon JR, Atherton-Skaff P, Perry A, Jenkins RB, James CD (1999) Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin Cancer Res 5:4085 4090.
24. Raisanen JM, Davis RL (1993) Congenital brain tumors. Pathology (Phila) 2:103 116.
25. Rekate H (2006) A report of nine newborns with congenital brain tumors. Childs Nerv Syst 22:1433.
26. Rickert CH (1999) Neuropathology and prognosis of foetal brain tumours. Acta Neuropathol (Berl) 98:567 576.
27. Rickert CH, Strater R, Kaatsch P, Wassmann H, Jurgens H, Dockhorn-Dworniczak B, Paulus W (2001) Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 158:1525 1532.
28. Rood BR, MacDonald TJ (2005) Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches. J Neurooncol 75:267 272.
29. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn V, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987 996.
30. Sung T, Miller DC, Hayes RL, Alonso M, Yee H, Newcomb EW (2000) Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Pathol 10:249 259.
31. Sure U, Ruedi D, Tachibana O, Yonekawa Y, Ohgaki H, Kleihues P, Hegi ME (1997) Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol 56:782 789.
32. Tamber MS, Rutka JT (2003) Pediatric supratentorial high-grade gliomas. Neurosurg Focus 14:e1.
33. Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57:684 689.
34. Turner CD, Chi S, Marcus KJ, Macdonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW (2007) Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol 82:95 101.
35. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217 223, discussion 23-24.
36. Winters JL, Wilson D, Davis DG (2001) Congenital glioblastoma multiforme: a report of three cases and a review of the literature. J Neurol Sci 188:13 19.